Kendall Law Group Investigates SenoRx, Inc. Merger for Shareholders
May 07 2010 - 12:02PM
Business Wire
Kendall Law Group, a national securities firm, is investigating
SenoRx, Inc. (NASDAQ: SENO) for shareholders in connection with the
proposed sale of the Company to C. R. Bard, Inc. The firm is
investigating whether Seno and its Board breached their fiduciary
duties by entering into the agreement without properly shopping for
a deal that would provide better value for shareholders. Seno
shareholders with information to contribute or seeking additional
information about your rights should contact the Kendall Law Group
at 877-744-3728 or by email at skendall@kendalllawgroup.com.
On May 5, 2010, Seno announced that it had entered into an
agreement to be acquired by C.R. Bard for $213 million. According
to the agreement, Seno shareholders will receive $11.00 per share,
representing a 14% premium over the closing price before the deal
was announced. However, SENO stock closed at $10.00 in late April,
2010. The firm is concerned that shareholders will not receive
proper value for their investment from the transaction. Since the
deal is expected to close by the end of the third quarter of 2010,
shareholders are encouraged to contact the firm as soon as
possible.
Kendall Law Group, founded by a former federal judge, includes a
former United States Attorney, prosecutors and securities lawyers
who are experienced in complex securities litigation. The firm has
been counsel in dozens of merger and acquisition cases nationwide,
including some of the largest transactions in the United
States.
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Oct 2024 to Nov 2024
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Senorx (MM) (NASDAQ): 0 recent articles
More Kendall Law Group News Articles